Anti-CD19 & CD3 Reference Antibody (Blinatumomab)
Produktgrößen
100 ug
£1151,00
CHBA068-100UG
1 mg
£2955,00
CHBA068-1MG
Über dieses Produkt
- SKU:
- CHBA068
- Zusätzliche Namen:
- Blinatumomab
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Lulizumab is a monovalent Anti-Human CD28 Domain Antibody Antagonist designed for the treatment of autoimmune diseases.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- CD19,CD3
- Molekulargewicht:
- 54.05 kDa
- Reinheit:
- >95%
- Aufreinigung:
- Protein A Purified
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -70[o]C Aliquot. Avoid freeze/thaw cycles., -20[o]C Aliquot. Avoid freeze/thaw cycles., 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Recombinant Antibodies
- Datenblatt des Herstellers:CHBA068